To our knowledge, there has been no evidence associating overexpression of IGIP with inflammatory or autoimmune diseases; however, overexpression of either APRIL, BAFF or TGF-β is associated with autoimmune diseases and cancer [34,35]. Here, TNFSF13B is linked to autoimmune disease.